搜索临床试验以：Nirmatrelvir 150 mg Ritonavir 100 mg (Reference first dose)
总计1285个结果
-
Merck Sharp & Dohme LLC完全的人类免疫缺陷病毒 1 (HIV-1)
-
Genuine Research Center, EgyptEva Pharma完全的
-
National and Kapodistrian University of Athens招聘中
-
Merck Sharp & Dohme LLC完全的
-
Immodulon Therapeutics LtdTheradex; HCA International Limited完全的
-
Atabay Kimya Sanayi Ticaret A.S.Novagenix Bioanalytical Drug R&D Center; Farmagen Ar-Ge Biyot. Ltd. Sti未知
-
Eisai Inc.主动，不招人乳腺肿瘤 | 受体，雌激素 | 基因，Erbb-2美国, 英国
-
Genuine Research Center, EgyptBio Med for Pharmaceuticals Industries (BIOMED), Egypt完全的
-
University of California, San FranciscoSan Francisco VA Health Care System完全的
-
Jair Bar, M.D., Ph.D.Merck Sharp & Dohme LLC完全的
-
GlaxoSmithKline完全的
-
Almirall, S.A.完全的
-
Medical College of WisconsinBarbara Ann Karmanos Cancer Institute; Cornerstone Pharmaceuticals招聘中
-
GlaxoSmithKlinePiramal Clinical Research (Hyderabad, India)完全的
-
GlaxoSmithKlinePiramal Clinical Research (Hyderabad, India)完全的
-
Lundbeck Canada Inc.完全的慢性淋巴细胞白血病 | 惰性非霍奇金淋巴瘤加拿大
-
The Lymphoma Academic Research OrganisationInstitute of Cancer Research, United Kingdom招聘中
-
University of FlorenceAzienda Ospedaliera Città della Salute e della Scienza di Torino; University of Roma La Sapienza 和其他合作者招聘中